SYZYGIUM JAMBOLANUM (Rxhomeo Private Limited d.b.a. Rxhomeo, Inc)


Welcome to the PulseAid listing for the SYZYGIUM JAMBOLANUM drug offered from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
NON-PROPRIETARY NAME: SYZYGIUM JAMBOLANUM
SUBSTANCE NAME: JUNIPERUS SABINA LEAFY TWIG
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-11-03
END MARKETING DATE: 0000-00-00


SYZYGIUM JAMBOLANUM HUMAN OTC DRUG Details:

Item DescriptionSYZYGIUM JAMBOLANUM from Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
LABELER NAME: Rxhomeo Private Limited d.b.a. Rxhomeo, Inc
DEA SCHEDULE:
ACTIVE STRENGTH: 3([hp_X]/1)
START MARKETING DATE: 2015-11-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 15631-0425_a05dd256-0f47-48df-aae1-05048cef75de
PRODUCT NDC: 15631-0425
APPLICATION NUMBER:

Other JUNIPERUS SABINA LEAFY TWIG Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Laboratoires BoironSabina
Paramesh Banerji Life Sciences LLCSabina 200C
Rxhomeo Private Limited d.b.a. Rxhomeo, IncSYZYGIUM JAMBOLANUM
Seroyal USASABINA